Literature DB >> 2106064

In situ localization and distribution of xenobiotic-activating enzymes and aryl hydrocarbon hydroxylase activity in lungs of untreated rats.

J M Voigt1, T T Kawabata, J P Burke, M V Martin, F P Guengerich, J Baron.   

Abstract

The present investigation was undertaken to more precisely establish where xenobiotics can be oxidatively metabolized and bioactivated within the lung. To accomplish this, antibodies raised against NADPH-cytochrome P-450 reductase (EC 1.6.2.4) and cytochromes P-450 BNF-B, PB-B, and PCN-E (the major forms of cytochrome P-450 induced by beta-naphthoflavone, phenobarbital, and pregnenolone-16 alpha-carbonitrile, respectively) that had been purified to apparent homogeneity from rat liver microsomes were used to determine the localizations and distributions of these enzymes immunohistochemically at the light microscopic level within lungs of untreated rats. Additionally, the intrapulmonary sites at which benzo(alpha)pyrene undergoes hydroxylation were identified in situ by means of fluorescence histochemistry. Immunohistochemical staining for NADPH-cytochrome P-450 reductase and cytochromes P-450 BNF-B, PB-B, and PCN-E was detected in bronchial epithelial cells, both ciliated and nonciliated (Clara) bronchiolar epithelial cells, and type II pneumocytes as well as other cells in the alveolar wall. Results of microfluorometric analyses of the immunofluorescence staining intensities of bronchial epithelial cells, Clara cells, and type II pneumocytes demonstrated further that Clara cells bound the antibodies raised to NADPH-cytochrome P-450 reductase and cytochrome P-450 PB-B to significantly greater extents than did bronchial epithelial cells and type II pneumocytes. Thus, in lungs of untreated rats, Clara cells contain the greatest amounts of these two enzymes. In marked contrast, the antibodies directed against cytochromes P-450 BNF-B and PCN-E were each bound to similar extents by bronchial epithelial cells, Clara cells, and type II pneumocytes. In agreement with immunohistochemical observations on the intrapulmonary localizations of NADPH-cytochrome P-450 reductase and cytochromes P-450 BNF-B, PB-B, and PCN-E in untreated rats, benzo(alpha)pyrene was hydroxylated in situ by bronchial and bronchiolar epithelial cells and alveolar wall cells, especially type II pneumocytes. These immunohistochemical and histochemical findings, thus, demonstrate that bronchial epithelial cells, Clara and ciliated bronchiolar epithelial cells, and type II pneumocytes as well as other alveolar wall cells represent sites for the in vivo oxidative metabolism and bioactivation of xenobiotics in lungs of untreated rats.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2106064

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  5 in total

1.  In vitro biotransformation of 2-methylpropene (isobutene) in rat lung tissue in comparison with liver tissue.

Authors:  M Cornet; A Callaerts; A Vercruysse; V Rogiers
Journal:  Arch Toxicol       Date:  1995       Impact factor: 5.153

2.  Characterization of Clara and type II cells isolated from rat lung by fluorescence-activated flow cytometry.

Authors:  J Martin; D Dinsdale; I N White
Journal:  Biochem J       Date:  1993-10-01       Impact factor: 3.857

3.  Immunohistochemical localization of cytochrome P450 3A in human pulmonary carcinomas and normal bronchial tissue.

Authors:  K T Kivistö; P Fritz; A Linder; G Friedel; P Beaune; H K Kroemer
Journal:  Histochem Cell Biol       Date:  1995-01       Impact factor: 4.304

4.  Immunohistochemical localization of cytochrome P450 2E1 in human pulmonary carcinoma and normal bronchial tissue.

Authors:  K T Kivistö; A Linder; G Friedel; P Beaune; C Belloc; H K Kroemer; P Fritz
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

5.  Cooperation of the inducible nitric oxide synthase and cytochrome P450 1A1 in mediating lung inflammation and mutagenicity induced by diesel exhaust particles.

Authors:  Hongwen Zhao; Mark W Barger; Joseph K H Ma; Vincent Castranova; Jane Y C Ma
Journal:  Environ Health Perspect       Date:  2006-08       Impact factor: 9.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.